Article
NRF2 expression level and estrogen function in BRCA1-mutated breast cancer.
BMC cancer - 21 Oct 2025
Derismahafi Zeinab, Farhud Dariush, Razavirad Amirhossein, Muhammadnejad Ahad, Jahanbin Behnaz, Farivar Shirin, Shirkoohi Reza
Abstract excerpt
BACKGROUND: Breast cancer (BC) is the most common malignancy diagnosed in women, with approximately 5–10% of cases attributed to hereditary factors. Although the tumor suppressor breast cancer susceptibility gene 1(BRCA1) is ubiquitously expressed, it is not clear why BRCA1 mutations overwhelmingly predispose to breast and ovarian cancers. Estrogen has been proposed to promote the survival of BRCA1-deficient...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
